Worth reading
62In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
10
Percentage of most recent consolidated net sales (at least %)Wording
Conditional
How definitive the wording is.Decision and Details
Sale of real estate held for sale
Decision17 March 2026
Implementation30 March 2026 (scheduled settlement date)
Going forwardThe sale contract is scheduled to be signed on 26 March 2026, with settlement scheduled for 30 March 2026
AmountSale price: an amount equivalent to at least 10% of consolidated net sales of ¥727,447 million for the fiscal year ended December 2025 (the specific sale price is undisclosed)
Quantity / scaleSite area: 10,839.95 m²; total floor area: 102,319.57 m²; 24 above-ground floors with 1 basement level; completed in February 2010 (16 years old)
Impact on Business Performance
Already reflected in the consolidated earnings forecast for the fiscal year ending December 2026
| Item | Details |
|---|---|
| Matter Covered | Sale of real estate held for sale |
| Decision Date | 17 March 2026 |
| Implementation Date | 30 March 2026 (scheduled settlement date) |
| Amount | Sale price: an amount equivalent to at least 10% of consolidated net sales of ¥727,447 million for the fiscal year ended December 2025 (the specific sale price is undisclosed) |
| Quantity / scale | Site area: 10,839.95 m²; total floor area: 102,319.57 m²; 24 above-ground floors with 1 basement level; completed in February 2010 (16 years old) |
| Impact on Business Performance | Already reflected in the consolidated earnings forecast for the fiscal year ending December 2026 |
| Related previous disclosures | “Summary of Financial Results for the Fiscal Year Ended December 2025 [Japanese GAAP] (Consolidated),” announced on 29 January 2026 |
| Future plans | The sale contract is scheduled to be signed on 26 March 2026, with settlement scheduled for 30 March 2026 |
Items this document does not state (4)
Decision-Making BodyPeriod CoveredReasonGoverning Rule
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.No reason for the sale was provided by the Company.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.